Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Cristina Sensi is active.

Publication


Featured researches published by Cristina Sensi.


Journal of Experimental Medicine | 2013

The oxysterol–CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophils

Laura Raccosta; Raffaella Fontana; Daniela Maggioni; Claudia Lanterna; Eduardo J. Villablanca; Aida Paniccia; Andrea Musumeci; Elena Chiricozzi; Maria Letizia Trincavelli; Simona Daniele; Claudia Martini; Jan Åke Gustafsson; Claudio Doglioni; Safiyè Gonzalvo Feo; Andrea Leiva; Maria Grazia Ciampa; Laura Mauri; Cristina Sensi; Alessandro Prinetti; Ivano Eberini; J. Rodrigo Mora; Claudio Bordignon; Knut R. Steffensen; Sandro Sonnino; Silvano Sozzani; Catia Traversari; Vincenzo Russo

Tumor-derived oxysterols recruit protumor neutrophils in an LXR-independent, CXCR2-dependent manner, thus favoring tumor growth by promoting neoangiogenesis and immunosuppression.


Journal of Computer-aided Molecular Design | 2011

In silico identification of new ligands for GPR17: a promising therapeutic target for neurodegenerative diseases

Ivano Eberini; Simona Daniele; Chiara Parravicini; Cristina Sensi; Maria Letizia Trincavelli; Claudia Martini; Maria P. Abbracchio

GPR17, a previously orphan receptor responding to both uracil nucleotides and cysteinyl-leukotrienes, has been proposed as a novel promising target for human neurodegenerative diseases. Here, in order to specifically identify novel potent ligands of GPR17, we first modeled in silico the receptor by using a multiple template approach, in which extracellular loops of the receptor, quite complex to treat, were modeled making reference to the most similar parts of all the class-A GPCRs crystallized so far. A high-throughput virtual screening exploration of GPR17 binding site with more than 130,000 lead-like compounds was then applied, followed by the wet functional and pharmacological validation of the top-scoring chemical structures. This approach revealed successful for the proposed aim, and allowed us to identify five agonists or partial agonists with very diverse chemical structure. None of these compounds could have been expected ‘a priori’ to act on a GPCR, and all of them behaved as much more potent ligands than GPR17 endogenous activators.


Journal of Proteomics | 2013

A proteomic portrait of atherosclerosis

Ivano Eberini; Robin Wait; Laura Calabresi; Cristina Sensi; Ingrid Miller; Elisabetta Gianazza

We have arranged in this review the main evidence about proteome alterations in different cell and body fluid compartments along the progression of atherosclerosis. With time the description of the molecular phenomena is becoming more and more detailed yet the complex interrelationships among different factors are still elusive and previously neglected aspects (such as size for lipoprotein particles) emerge as not less relevant than the absolute abundance of individual proteins. Physiological limits to the kinetics of protein distribution through the biological fluids seem to hinder the early diagnosis of acute conditions through plasma analysis but suggest urine analysis as a workable alternative for the assessment of chronic conditions. The survey of literature data is complemented with a few unpublished results from our laboratories, featuring 2DE maps of the proteins extracted from human thrombi.


PLOS ONE | 2014

A computational approach to evaluate the androgenic affinity of iprodione, procymidone, vinclozolin and their metabolites.

C. Galli; Cristina Sensi; Amos Fumagalli; Chiara Parravicini; Marina Marinovich; Ivano Eberini

Our research is aimed at devising and assessing a computational approach to evaluate the affinity of endocrine active substances (EASs) and their metabolites towards the ligand binding domain (LBD) of the androgen receptor (AR) in three distantly related species: human, rat, and zebrafish. We computed the affinity for all the selected molecules following a computational approach based on molecular modelling and docking. Three different classes of molecules with well-known endocrine activity (iprodione, procymidone, vinclozolin, and a selection of their metabolites) were evaluated. Our approach was demonstrated useful as the first step of chemical safety evaluation since ligand-target interaction is a necessary condition for exerting any biological effect. Moreover, a different sensitivity concerning AR LBD was computed for the tested species (rat being the least sensitive of the three). This evidence suggests that, in order not to over−/under-estimate the risks connected with the use of a chemical entity, further in vitro and/or in vivo tests should be carried out only after an accurate evaluation of the most suitable cellular system or animal species. The introduction of in silico approaches to evaluate hazard can accelerate discovery and innovation with a lower economic effort than with a fully wet strategy.


Journal of Proteomics | 2012

Proteomics of rat biological fluids--the tenth anniversary update.

Elisabetta Gianazza; Robin Wait; Ivano Eberini; Cristina Sensi; Luigi Sironi; Ingrid Miller

In addition to a remarkable sexual dimorphism of serum and urine proteomes, the rat is exceptional for the wide difference between the serum patterns during an acute phase reaction vs baseline conditions. This feature allows monitoring with high sensitivity onset and progression of any pathological state that involves an inflammatory component as well as assessing the outcome of any therapeutic intervention. Reference maps have been defined for the proteomes of serum, urine, cerebrospinal fluid and bronchoalveolar lavage fluid. For both serum and urine most of the proteomic investigations have dealt with toxicological testing, for BALF with allergic or irritative reactions, whereas with CSF the main aim was the characterization of rat models of neurological disorders. When surveying more than ten years of literature on rat biological fluid proteomics, it is puzzling to see how seldom a consistent analytical plan has been set up for the comparative investigation on two or more types of sample, whether to fully characterize a disease model or to evaluate pharmacological/toxicological effects of a drug. It is also regrettable that in several cases only a negligible part of the results is discussed at length whereas most data are not even made known to the scientific community.


Journal of Molecular Graphics & Modelling | 2011

Simulation of urea-induced protein unfolding: a lesson from bovine β-lactoglobulin.

Ivano Eberini; Andrew Emerson; Cristina Sensi; Laura Ragona; Piero Ricchiuto; Alessandro Pedretti; Elisabetta Gianazza; Anna Tramontano

To investigate the molecular mechanisms involved in the very initial stages of protein unfolding, we carried out one long (1 μs) simulation of bovine β-lactoglobulin (BLG) together with three (500 ns) supporting MD runs, in which the unfolding conditions were produced by adding the osmolyte urea to the simulated systems and/or by increasing the thermal energy raising the temperature from 300 to 350 K. BLG was chosen, since it is a well-characterized model protein, for which structural and folding properties have been widely investigated by X-ray and NMR. MD trajectories were analyzed not only in terms of standard progress variables, such as backbone H-bonds, gyration radius width, secondary structure elements, but also through the scrutiny of interactions and dynamical behavior of specific key residues previously pointed out and investigated by NMR and belonging to a well known hydrophobic cluster. MD trajectories simulated in different unfolding conditions suggest that urea destabilizes BLG structure weakening protein::protein hydrophobic interactions and the hydrogen bond network. The early unfolding events, better observed at higher temperature, affect both secondary and tertiary structure of the protein.


Journal of Proteomics | 2014

In between — Proteomics of dog biological fluids

Ingrid Miller; Andrea Preßlmayer-Hartler; Robin Wait; Karin Hummel; Cristina Sensi; Ivano Eberini; Ebrahim Razzazi-Fazeli; Elisabetta Gianazza

Dogs are relevant to biomedical research in connection both to veterinary medicine for their role as pets and to basic investigations for their use as animal models in pathology, pharmacology and toxicology studies. Proteomic analysis of biological fluids is less advanced for dogs than for other animal species but a wealth of information has already been gathered, which we summarize in this review. As a remarkable feature, we also assemble here for due reference a number of 2-DE serum/plasma or urine patterns in health and disease; some of them correspond to unpublished data from the University of Veterinary Medicine Vienna.


Proteomics | 2012

Neglected markers: altered serum proteome in murine models of disease.

Elisabetta Gianazza; Elisabetta Vegeto; Ivano Eberini; Cristina Sensi; Ingrid Miller

More than a decade ago our groups pioneered the analysis of serum proteins of laboratory animals with up‐to‐date proteomic techniques. We were, and still are, convinced that conforming animal procedures to the minimally invasive approaches typical of clinical biochemistry focuses attention on the actual conditions under which any finding arrived at on animal models of disease may eventually be applied to human patients for screening/diagnosis. We are also convinced that, besides the proteins present in trace level as a result of tissue leakage during disorders affecting specific peripheral organs, changes in the concentration of some of the major serum proteins as part of an acute‐phase response may be taken as biological end‐points during a number of experimental procedures. When reviewing literature data about proteomic investigations on plasma or serum of mice, we realized that not much work has been done in the direction we favor. In addition, we noticed that sometimes information about serum proteome has been coarsely treated and in a few cases even misunderstood/misused. In the following, we present current findings on serum/plasma proteome of the laboratory mouse not only under control conditions and during an experimentally induced acute‐phase reaction, but also in a number of models of disease, mainly related to cancer and to metabolic disorders.


Proteomics | 2011

Energy matters: Mitochondrial proteomics for biomedicine

Elisabetta Gianazza; Ivano Eberini; Cristina Sensi; Maria Barile; Lodovica Vergani; Maria A. Vanoni

This review compiles results of medical relevance from mitochondrial proteomics, grouped either according to the type of disease – genetic or degenerative – or to the involved mechanism – oxidative stress or apoptosis. The findings are commented in the light of our current understanding of uniformity/variability in cell responses to different stimuli. Specificities in the conceptual and technical approaches to human mitochondrial proteomics are also outlined.


Proteins | 2014

Unfolding of beta‐lactoglobulin on the surface of polystyrene nanoparticles: Experimental and computational approaches

Matteo Miriani; Ivano Eberini; Stefania Iametti; Pasquale Ferranti; Cristina Sensi; Francesco Bonomi

Structural changes ensuing from the non‐covalent absorption of bovine beta‐lactoglobulin (BLG) on the surface of polystyrene nanoparticles were investigated by using spectroscopic approaches, by assessing the reactivity of specific residues, and by limited proteolysis/mass spectrometry. Also, the immunoreactivity of absorbed and free BLG was compared. All these approaches indicated substantial rearrangements of the protein structure in the absorbed state, in spite of the reported structural rigidity of BLG. Changes made evident by experimental measurements were confirmed by computational approaches. These indicate that adsorption‐related changes are most marked in the area between the main C‐terminal alpha helix and the beta‐barrel, and lead to full exposure of the thiol on Cys121, consistent with experimental measurements. In the computational model of bound BLG, both Trp61 and Trp19 also move away from their neighboring quenchers and become solvent‐exposed, as indicated by fluorescence measurement. Upon binding, the beta‐barrel also loosens, with a substantial increase in immunoreactivity and with noticeable changes in the trypsinolytic pattern. The possible general significance of the structural changes reported here for non‐covalently adsorbed BLG is discussed with respect to recognition events involving surface‐bound proteins, as are aspects related to the carrier function(s) of BLG, and to its use as a common ingredient in many food systems. Proteins 2014; 82:1272–1282.

Collaboration


Dive into the Cristina Sensi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ingrid Miller

University of Veterinary Medicine Vienna

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge